Deep Medicine Acquisition Executives

DMAQDelisted Stock  USD 11.59  0.12  1.02%   
Deep Medicine employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Discussion of Deep Medicine's management performance can provide insight into the enterprise performance.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Deep Medicine Management Team Effectiveness

The company has return on total asset (ROA) of (0.0176) % which means that it has lost $0.0176 on every $100 spent on assets. This is way below average. Deep Medicine's management efficiency ratios could be used to measure how well Deep Medicine manages its routine affairs as well as how well it operates its assets and liabilities.

Deep Medicine Workforce Comparison

Deep Medicine Acquisition is rated # 5 in number of employees category among its peers. The total workforce of Financials industry is currently estimated at about 242. Deep Medicine maintains roughly 2.0 in number of employees contributing less than 1% to equities under Financials industry.

Deep Medicine Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Deep Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Deep Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Deep Medicine insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Deep Medicine Notable Stakeholders

A Deep Medicine stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Deep Medicine often face trade-offs trying to please all of them. Deep Medicine's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Deep Medicine's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Humphrey PolanenCEO ChairmanProfile
MS CPAChief OfficerProfile

About Deep Medicine Management Performance

The success or failure of an entity such as Deep Medicine Acquisition often depends on how effective the management is. Deep Medicine management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Deep management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Deep management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Deep Medicine Acquisition Corp. does not have significant operations. The company was incorporated in 2020 and is based in New York, New York. Deep Medicine is traded on NASDAQ Exchange in the United States.

Deep Medicine Workforce Analysis

Traditionally, organizations such as Deep Medicine use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Deep Medicine within its industry.

Deep Medicine Manpower Efficiency

Return on Deep Medicine Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee200.1K
Net Loss Per Executive200.1K
Working Capital Per Employee3.5M
Working Capital Per Executive3.5M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Deep Stock

If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets